Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131

Saved in:
Bibliographic Details
Published inAntimicrobial agents and chemotherapy Vol. 62; no. 1
Main Authors Rodríguez-Villodres, Ángel, Ortiz de la Rosa, José Manuel, Álvarez-Marín, Rocío, Pachón, Jerónimo, Aznar, Javier, Lepe, José Antonio, Smani, Younes
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.01.2018
Subjects
Anti-Bacterial Agents
Commented On
Drug Resistance, Multiple, Bacterial
Escherichia coli
Letter to the Editor
Letters to the Editor
Piperacillin
Piperacillin, Tazobactam Drug Combination
Tazobactam
heteroresistance
Escherichia coli
ST131
piperacillin-tazobactam
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
Citation Rodríguez-Villodres Á, Ortiz de la Rosa JM, Álvarez-Marín R, Pachón J, Aznar J, Lepe JA, Smani Y. 2018. Heteroresistance to piperacillin-tazobactam in clinical isolates of Escherichia coli sequence type 131. Antimicrob Agents Chemother 62:e01923-17. https://doi.org/10.1128/AAC.01923-17.
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.01923-17